829.43
0.07%
0.59
시간 외 거래:
829.44
0.01
+0.00%
Regeneron Pharmaceuticals Inc (REGN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
8.42%
3,145.00
|
3,434.30 | 3,362.70 | 3,158.10 | 3,162.10 |
Operating Expenses
|
2.75%
2,393.60
|
2,461.40 | 2,251.70 | 2,141.60 | 2,215.40 |
Interest Income/Expense |
12.02%
16.10
|
18.30 | 17.80 | 18.90 | 18.00 |
Benefits Costs and Expenses |
6.89%
2,444.30
|
2,286.70 | 2,251.90 | 2,075.20 | 2,304.10 |
Costs And Expenses |
2.75%
2,393.60
|
2,461.40 | 2,251.70 | 2,141.60 | 2,215.40 |
Operating Income/Loss |
22.77%
751.40
|
972.90 | 1,111.00 | 1,016.50 | 946.70 |
Nonoperating Income/Loss |
129.02%
-50.70
|
174.70 | -0.20 | 66.40 | -88.70 |
Income/Loss From Continuing Operations Before Tax |
38.94%
700.70
|
1,147.60 | 1,110.80 | 1,082.90 | 858.00 |
Income Tax Expense/Benefit |
77.50%
-21.30
|
-12.00 | 103.00 | 114.50 | 40.20 |
Income/Loss From Continuing Operations After Tax |
37.74%
722.00
|
1,159.60 | 1,007.80 | 968.40 | 817.80 |
Net Income/Loss
|
37.74%
722.00
|
1,159.60 | 1,007.80 | 968.40 | 817.80 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
107.90K%
107.80
|
-0.10 | 106.30 | 107.00 | 107.10 |
Diluted Average Shares |
115.10
|
- | 113.40 | 113.90 | 114.00 |
Basic Earnings Per Share |
38.48%
6.70
|
10.89 | 9.48 | 9.05 | 7.64 |
Diluted Earnings Per Share |
38.53%
6.27
|
10.20 | 8.89 | 8.50 | 7.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):